{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:53:05Z","timestamp":1782215585051,"version":"3.54.5"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"S2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1186\/s13071-017-2431-y","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T09:11:48Z","timestamp":1510218708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Evaluation of the efficacy of ProHeart\u00ae 6 (moxidectin) against a resistant isolate of Dirofilaria immitis (JYD-34) in dogs"],"prefix":"10.1186","volume":"10","author":[{"given":"Dwight D.","family":"Bowman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom L.","family":"McTier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Mahabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce A.","family":"Login","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Bidgood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra J.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"2431_CR1","unstructured":"New Animal Drug Application, NADA 141\u2013189, June 06, 2001, Freedom of Information Summary, ProHeart\u00ae 6 (moxidectin) Sustained Release Injectable for dogs. \nhttp:\/\/www.fda.gov\/downloads\/AnimalVeterinary\/Products\/ApprovedAnimalDrugProducts\/FOIADrugSummaries\/ucm117588.pdf\n\n. Accessed on 10 Dec 2016."},{"key":"2431_CR2","unstructured":"Bowman DD, Lee ACY, Harrington LC, Ledesma NA, et al. Testing the efficacy of injectable moxidectin formulation (ProHeart\u00ae 6) against a field isolate of canine heartworm, Proceedings of the 58\n                    \n                        th\n                    \n                    annual meeting of the American Association of Veterinary Parasitologists. Chicago; 2013. Abstract 32"},{"key":"2431_CR3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.vetpar.2015.04.002","volume":"210","author":"C Bourguinat","year":"2015","unstructured":"Bourguinat C, Lee A, Lizunda R, Blagburn B, Liotta J, Kraus M, et al. Macrocyclic lactone resistance in Dirofilaria immitis: failure of heartworm preventives and investigation of genetic markers for resistance. Vet Parasitol. 2015;210:167\u201378.","journal-title":"Vet Parasitol"},{"key":"2431_CR4","unstructured":"VICH. Efficacy of anthelmintics: specific recommendations for canines. VICH GL19 (Anthelmintics: canine). June. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products. \nhttp:\/\/www.fda.gov\/downloads\/animalveterinary\/guidancecomplianceenforcement\/guidanceforindustry\/ucm052652.pdf\n\n. Last Accessed 10 Dec 2016."},{"key":"2431_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13071-016-1476-7","volume":"9","author":"BL Blagburn","year":"2016","unstructured":"Blagburn BL, Arther RG, Dillon AR, Butler JM, et al. Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis. Parasit Vectors. 2016;9:191.","journal-title":"Parasit Vectors"},{"key":"2431_CR6","unstructured":"European Medicines Agency (EMA), Committee for Medicinal Products for Veterinary Use (CVMP) 2014 Assessment report for NEXGARD SPECTRA (EMEA\/V\/C\/003842\/0000). \nhttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/veterinary\/003842\/WC500181963.pdf\n\n. Last Accessed on 26 Sep 2015."},{"issue":"1","key":"2431_CR7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s13071-014-0494-6","volume":"7","author":"CN Pulaski","year":"2014","unstructured":"Pulaski CN, Malone JB, Bourguinat C, Prichard R, Delcambre B, et al. Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs. Parasit Vectors. 2014;7(1):494.","journal-title":"Parasit Vectors"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-017-2431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T09:13:26Z","timestamp":1510218806000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-017-2431-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":7,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2431"],"URL":"https:\/\/doi.org\/10.1186\/s13071-017-2431-y","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]},"article-number":"502"}}